Light TherapyResearchResearch for the PublicLight Therapy Improves Blood Sugar in DepressionMarch 18, 2026by Chris Aiken, MD0
AlcoholCannabisCocaineMethamphetamineOpioidsResearchSubstance UseSupplementsProbiotics Fail in Substance-Induced DepressionMarch 18, 2026by Chris Aiken, MD0
DepressionNeuromodulation/TMSResearchResearch for the PublicTop ResearchFlow: At-home tDCS Approved for DepressionMarch 17, 2026by Chris Aiken, MD0
DepressionDevicesDifficult to Treat DepressionNeuromodulation/TMSResearchResearch for the PublicTop ResearchA Wearable Headset for Difficult-to-Treat DepressionMarch 15, 2026by Chris Aiken, MD0
DementiaGLP1 AgonistsResearchTop ResearchTwo GLP-1 Agonists Fail in DementiaJanuary 25, 2026by Chris Aiken, MD0
CognitionDepressionGLP1 AgonistsResearchResearch for the PublicTop ResearchSemaglutide (Ozempic) in DepressionDecember 5, 2025by Chris Aiken, MD0
DepressionResearchSupplementsTop ResearchLavender for DepressionSeptember 27, 2025by Chris Aiken, MD0
AntidepressantsDepressionDifficult to Treat DepressionLithiumMedicationsTop ResearchA New Version of the STAR*D TrialJune 18, 2025by Chris Aiken, MD0
DepressionResearchTop ResearchPramipexole for Treatment-Resistant DepressionJune 15, 2025by Chris Aiken, MD0
Child PsychiatryMedicationsResearchTop ResearchGuanfacine for Aggression in Prader-Willi SyndromeMay 21, 2025by Chris Aiken, MD0
GLP1 AgonistsMed-PsychResearchGLP1 Agonist Fails in Parkinson’s DiseaseFebruary 4, 2025by Chris Aiken, MD0
ADHDCannabisMedicationsResearchStimulantsSubstance UseAdderall for ADHD and Cannabis Use Disorder?September 4, 2024by Chris Aiken, MD1
AntipsychoticsMedicationsSchizophrenia and PsychosisTop ResearchAntipsychotic Reduction in Schizophrenia: A Cautionary TaleNovember 10, 2023by Chris Aiken, MD0
DepressionMedicationsResearchTop ResearchEsketamine Beats Quetiapine in Treatment-Resistant DepressionOctober 23, 2023by Chris Aiken, MD0
AlcoholGLP1 AgonistsResearchA GLP-1 Agonist Fails in Alcohol Use DisorderOctober 11, 2022by Chris Aiken, MD0